Latest Shareholder Equity News

Strike Resources signals potential for an additional A$5 million capital raise through oversubscriptions, pending board approval, with new shares under Tranche 2 set to follow the Share Purchase Plan issuance.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.

Accelerate Resources has kicked off its maiden drilling campaign at the Kanowna Gold East Project, refining targets through advanced gravity surveys, while bolstering its cash reserves with a $2 million non-dilutive injection.

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

Imperial Pacific reports a solid 14.4% increase in net worth for FY2025, driven by strong investment gains and strategic moves including reinstating its Dividend Reinvestment Plan.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

I Synergy Group Limited has successfully raised approximately $1 million through a fully underwritten entitlement offer, with robust shareholder participation and full underwriting support.

Opyl Limited has taken a bold step into digital assets by acquiring approximately 2 Bitcoin and securing a $2 million finance facility backed by these holdings, signaling a strategic pivot towards blockchain integration in healthcare technology.

Everest Metals has been accepted into the US Defence Industrial Base Consortium, unlocking strategic collaboration and funding opportunities for its Mt Edon Rubidium Project in Western Australia. This milestone advances Australia’s first commercial rubidium production, addressing critical global supply shortages.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.